26 February 2016 - The ABPI is disappointed by today's decision by NHS England that it will continue to push ahead with largely unchanged proposals for a new Cancer Drugs Fund. This carries the very real risk of significantly setting back patient access to cancer medicines, now and for the foreseeable future.

For more details, go to: http://www.abpi.org.uk/media-centre/newsreleases/2016/Pages/250216.aspx